by susuguo | Jun 28, 2022
By Tomas J. Philipson Patients could become the collateral damage of a tug of war that Washington is playing between lowering drug prices and lowering the death rate from cancer. It comes at a moment when the White House’s proposed Cancer Moonshot initiative took...
by susuguo | Jun 13, 2022
Empirical evidence demonstrates that shutting down economies and schools brought little benefit and much harm. Did the Covid lockdowns save lives? Statistics can help answer the question. In April, free-market economists Phil Kerpen, Stephen Moore, and Casey B....
by sfrazee | Apr 20, 2022
Health, Ageing and Longevity Conference, April 20–22, 2022, London Business School Experts on longevity and ageing worked jointly during the four day collaborative conference between London Business School, University of Southern California, National University...
by susuguo | Apr 12, 2022
By Casey Mulligan Executive Summary Contrary to common criticisms, employer-sponsored insurance (ESI) provides significant value to beneficiaries and taxpayers far beyond the cost of the tax subsidy. Employees value ESI at 75–84 percent more than employers and...
